Ventyx Biosciences, Inc.
VTYXDelisted Mar 4, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851194
Ventyx Biosciences, Inc. was delisted on Mar 4, 2026; its insiders filed their last Form 4 on Mar 4, 2026; 139 institutions reported holding it in 13F filings for Q4 2025, worth $471.6M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Ventyx Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +21 vs. Q3 2022
- Shares held
- 42.6M
- +3.34M (+8.5%) vs. Q3 2022
- Total value
- $1.40B
- +$25.2M (+1.8%) vs. Q3 2022
- New holders
- 37
- 54 more added
- Sold out
- 16
- 21 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VTYX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 1 | $21.0K |
| Q4 2025 | 139 | $471.6M |
| Q3 2025 | 110 | $136.4M |
| Q2 2025 | 114 | $95.1M |
| Q1 2025 | 116 | $51.1M |
| Q4 2024 | 124 | $119.2M |
| Q3 2024 | 118 | $114.4M |
| Q2 2024 | 117 | $132.3M |
| Q1 2024 | 126 | $323.8M |
| Q4 2023 | 121 | $106.8M |
| Q3 2023 | 138 | $1.90B |
| Q2 2023 | 150 | $1.73B |
| Q1 2023 | 146 | $1.67B |
| Q4 2022 | 125 | $1.40B |
| Q3 2022 | 104 | $1.37B |
| Q2 2022 | 63 | $423.5M |
| Q1 2022 | 55 | $448.4M |
| Q4 2021 | 46 | $619.3M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Ventyx Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 552,006 | $18.1M | 0.00% | +111,063+25.2% | Added |
| Wellington Management Group LLP | 610,273 | $20.0M | 0.00% | −187,172−23.5% | Reduced |
| Logos Global Management LP | 657,016 | $21.5M | 2.52% | −740,664−53.0% | Reduced |
| Qiming U.S. Ventures Management, LLC | 746,370 | $24.5M | 32.37% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 787,231 | $25.8M | 4.56% | +787,231 | New |
| Boxer Capital, LLC | 850,000 | $27.9M | 1.50% | 00.0% | Unchanged |
| Redmile Group, LLC | 894,974 | $29.3M | 1.20% | −470,026−34.4% | Reduced |
| OrbiMed Advisors LLC | 925,000 | $30.3M | 0.58% | +700,000+311.1% | Added |
| Third Point LLCSuperinvestorThird Point | 1,000,000 | $32.8M | 0.55% | −3,312,834−76.8% | Reduced |
| Driehaus Capital Management LLC | 1,012,320 | $33.2M | 0.49% | +3,217+0.3% | Added |
| Cormorant Asset Management, LP | 1,080,643 | $35.4M | 2.38% | +299,997+38.4% | Added |
| Pictet Asset Management SA | 1,227,972 | $40.3M | 0.06% | +155,989+14.6% | Added |
| Avidity Partners Management LP | 1,285,000 | $42.1M | 0.98% | +1,285,000 | New |
| Vivo Capital, LLC | 1,303,294 | $42.7M | 5.18% | −52,567−3.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,421,245 | $46.6M | 0.11% | +1,021,245+255.3% | Added |
| Janus Henderson Group PLC | 1,463,772 | $48.0M | 0.03% | +149,233+11.4% | Added |
| Vanguard Group Inc | 1,496,171 | $49.1M | 0.00% | +392,218+35.5% | Added |
| RTW Investments, LP | 1,551,778 | $50.9M | 1.04% | 00.0% | Unchanged |
| FMR LLC | 1,694,487 | $55.6M | 0.01% | −201,325−10.6% | Reduced |
| Price T Rowe Associates Inc | 1,805,574 | $59.2M | 0.01% | +1,120,232+163.5% | Added |
| Lord, Abbett & Co. LLC | 1,843,407 | $60.4M | 0.22% | +105,629+6.1% | Added |
| BlackRock Inc. | 1,969,863 | $64.6M | 0.00% | +588,360+42.6% | Added |
| Capital International Investors | 2,114,744 | $69.3M | 0.02% | +2,114,744 | New |
| venBio Partners LLC | 3,461,536 | $113.5M | 35.19% | −1,550,000−30.9% | Reduced |
| Citadel Advisors LLC | 3,767,343 | $123.5M | 0.14% | +296,179+8.5% | Added |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −1,401,123−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −207,925−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Tri Locum Partners LP | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −29,400−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −24,089−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −22,400−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −19,114−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,936−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −11,867−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −11,123−100.0% | Sold out |
| Tokio Marine Asset Management Co Ltd | 0 | $0 | 0.00% | −7,800−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −650−100.0% | Sold out |